Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Market Definitions
1.1.1.1. Type Segment
1.1.1.2. End-use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing prevalence of cardiovascular diseases
3.2.1.2. Rising number of emergency care cases
3.2.1.3. Surge in technologically advanced product approvals and launches
3.2.2. Market Restraint Analysis
3.2.2.1. Restriction for the patient suffering from osteoporosis
3.3. Business Environment Analysis
3.3.1. PESTLE Analysis
3.3.2. Porter’s Five Forces Analysis
Chapter 4. Intraosseous Infusion Devices Market – Segment Analysis, by Type, 2018 – 2030 (USD Million)
4.1. Intraosseous Infusion Devices Market: Type Dashboard
4.2. Intraosseous Infusion Devices Market: Type Movement Analysis
4.3. Intraosseous Infusion Devices Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Manual IO Needles
4.4.1. Manual IO Needles Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.5. Battery Powered Driver
4.5.1. Battery Powered Driver Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.6. Impact Driven Devices
4.6.1. Impact Driven Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
Chapter 5. Intraosseous Infusion Devices Market – Segment Analysis, by End-use, 2018 – 2030 (USD Million)
5.1. Intraosseous Infusion Devices Market: End-use Dashboard
5.2. Intraosseous Infusion Devices Market: End-use Movement Analysis
5.3. Intraosseous Infusion Devices Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
5.4. Hospitals and Clinics
5.4.1. Hospitals and Clinics Market Estimates and Forecasts, 2018 to 2030 (USD Million)
5.5. Ambulatory Surgical Centers
5.5.1. Ambulatory Surgical Centers Market Estimates and Forecasts, 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Others Market Estimates and Forecasts, 2018 to 2030 (USD Million)
Chapter 6. Regional Estimates & Trend Analysis by Country, Type, and End-use
6.1. Regional Dashboard
6.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
6.3. North America
6.3.1. North America Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.3.2. U.S.
6.3.2.1. U.S. Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.3.2.2. Key Country Dynamics
6.3.2.3. Regulatory Framework
6.3.2.4. Competitive Scenario
6.3.3. Canada
6.3.3.1. Canada Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.3.3.2. Key Country Dynamics
6.3.3.3. Regulatory Framework
6.3.3.4. Competitive Scenario
6.4. Europe
6.4.1. Europe Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.4.2. Germany
6.4.2.1. Germany Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.4.2.2. Key Country Dynamics
6.4.2.3. Regulatory Framework
6.4.2.4. Competitive Scenario
6.4.3. UK
6.4.3.1. UK Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.4.3.2. Key Country Dynamics
6.4.3.3. Regulatory Framework
6.4.3.4. Competitive Scenario
6.4.4. France
6.4.4.1. France Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.4.4.2. Key Country Dynamics
6.4.4.3. Regulatory Framework
6.4.4.4. Competitive Scenario
6.4.5. Italy
6.4.5.1. Italy Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.4.5.2. Key Country Dynamics
6.4.5.3. Regulatory Framework
6.4.5.4. Competitive Scenario
6.4.6. Spain
6.4.6.1. Spain Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.4.6.2. Key Country Dynamics
6.4.6.3. Regulatory Framework
6.4.6.4. Competitive Scenario
6.4.7. Denmark
6.4.7.1. Denmark Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.4.7.2. Key Country Dynamics
6.4.7.3. Regulatory Framework
6.4.7.4. Competitive Scenario
6.4.8. Sweden
6.4.8.1. Sweden Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.4.8.2. Key Country Dynamics
6.4.8.3. Regulatory Framework
6.4.8.4. Competitive Scenario
6.4.9. Norway
6.4.9.1. Norway Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.4.9.2. Key Country Dynamics
6.4.9.3. Regulatory Framework
6.4.9.4. Competitive Scenario
6.5. Asia Pacific
6.5.1. Asia Pacific Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.5.2. Japan
6.5.2.1. Japan Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.5.2.2. Key Country Dynamics
6.5.2.3. Regulatory Framework
6.5.2.4. Competitive Scenario
6.5.3. China
6.5.3.1. China Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.5.3.2. Key Country Dynamics
6.5.3.3. Regulatory Framework
6.5.3.4. Competitive Scenario
6.5.4. India
6.5.4.1. India Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.5.4.2. Key Country Dynamics
6.5.4.3. Regulatory Framework
6.5.4.4. Competitive Scenario
6.5.5. South Korea
6.5.5.1. South Korea Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.5.5.2. Key Country Dynamics
6.5.5.3. Regulatory Framework
6.5.5.4. Competitive Scenario
6.5.6. Australia
6.5.6.1. Australia Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.5.6.2. Key Country Dynamics
6.5.6.3. Regulatory Framework
6.5.6.4. Competitive Scenario
6.5.7. Thailand
6.5.7.1. Thailand Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.5.7.2. Key Country Dynamics
6.5.7.3. Regulatory Framework
6.5.7.4. Competitive Scenario
6.6. Latin America
6.6.1. Latin America Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.6.2. Brazil
6.6.2.1. Brazil Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.6.2.2. Key Country Dynamics
6.6.2.3. Regulatory Framework
6.6.2.4. Competitive Scenario
6.6.3. Mexico
6.6.3.1. Mexico Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.6.3.2. Key Country Dynamics
6.6.3.3. Regulatory Framework
6.6.3.4. Competitive Scenario
6.6.4. Argentina
6.6.4.1. Argentina Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.6.4.2. Key Country Dynamics
6.6.4.3. Regulatory Framework
6.6.4.4. Competitive Scenario
6.7. MEA
6.7.1. MEA Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.7.2. South Africa
6.7.2.1. South Africa Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.7.2.2. Key Country Dynamics
6.7.2.3. Regulatory Framework
6.7.2.4. Competitive Scenario
6.7.3. Saudi Arabia
6.7.3.1. Saudi Arabia Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.7.3.2. Key Country Dynamics
6.7.3.3. Regulatory Framework
6.7.3.4. Competitive Scenario
6.7.4. UAE
6.7.4.1. UAE Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.7.4.2. Key Country Dynamics
6.7.4.3. Regulatory Framework
6.7.4.4. Competitive Scenario
6.7.5. Kuwait
6.7.5.1. Kuwait Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.7.5.2. Key Country Dynamics
6.7.5.3. Regulatory Framework
6.7.5.4. Competitive Scenario
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Strategy Mapping
7.2.1. Acquisition
7.2.2. Collaborations
7.2.3. New Platform Launches
7.2.4. Others
7.3. Company Profiles/Listing
7.3.1. Aero Healthcare AU Pty Ltd
7.3.1.1. Company Overview
7.3.1.2. Financial Performance
7.3.1.3. Platform Benchmarking
7.3.1.4. Strategic Initiatives
7.3.2. Teleflex Incorporated
7.3.2.1. Company Overview
7.3.2.2. Financial Performance
7.3.2.3. Platform Benchmarking
7.3.2.4. Strategic Initiatives
7.3.3. Becton, Dickinson and Company
7.3.3.1. Company Overview
7.3.3.2. Financial Performance
7.3.3.3. Platform Benchmarking
7.3.3.4. Strategic Initiatives
7.3.4. BIOPSYBELL S.R.L.
7.3.4.1. Company Overview
7.3.4.2. Financial Performance
7.3.4.3. Platform Benchmarking
7.3.4.4. Strategic Initiatives
7.3.5. Cook Group
7.3.5.1. Company Overview
7.3.5.2. Financial Performance
7.3.5.3. Platform Benchmarking
7.3.5.4. Strategic Initiatives
7.3.6. SAM Medical
7.3.6.1. Company Overview
7.3.6.2. Financial Performance
7.3.6.3. Platform Benchmarking
7.3.6.4. Strategic Initiatives
7.3.7. Argon Medical Devices, Inc.
7.3.7.1. Company Overview
7.3.7.2. Financial Performance
7.3.7.3. Platform Benchmarking
7.3.7.4. Strategic Initiatives
7.3.8. Cardinal Health, Inc.
7.3.8.1. Company Overview
7.3.8.2. Financial Performance
7.3.8.3. Platform Benchmarking
7.3.8.4. Strategic Initiatives
7.3.9. Medax SRL Unipersonle
7.3.9.1. Company Overview
7.3.9.2. Financial Performance
7.3.9.3. Platform Benchmarking
7.3.9.4. Strategic Initiatives
7.3.10. StarFish Medical
7.3.10.1. Company Overview
7.3.10.2. Financial Performance
7.3.10.3. Platform Benchmarking
7.3.10.4. Strategic Initiatives
|